+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Fabry Disease Treatment Market Research Report by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, and Organ-specific Treatment), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989675
  • Report
  • July 2021
  • Region: Global
  • 184 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Fabry Disease Treatment Market will Grow to USD 3,186.50 Million by 2026, at a CAGR of 8.28%

FEATURED COMPANIES

  • Amicus Therapeutics Inc.
  • Avrobio Inc.
  • Greenovation Biotech GmbH
  • ISU Abxis Co Ltd.
  • Moderna Therapeutics Inc.
  • Sanofi S.A.
  • MORE
The Global Fabry Disease Treatment Market size was estimated at USD 1,976.98 Million in 2020 and expected to reach USD 2,134.00 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.28% to reach USD 3,186.50 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Fabry Disease Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the Fabry Disease Treatment Market was studied across Chaperone Treatment, Enzyme Replacement Therapy, Organ-specific Treatment, and Substrate Reduction Therapy.
  • Based on Region, the Fabry Disease Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Fabry Disease Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Fabry Disease Treatment Market, including Amicus Therapeutics Inc., Avrobio Inc., Greenovation Biotech GmbH, Idorsia Pharmaceuticals Ltd., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Moderna Therapeutics Inc., Protalix Biotherapeutics Inc., Sanofi S.A., and Shire Plc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Fabry Disease Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Fabry Disease Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Fabry Disease Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Fabry Disease Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Fabry Disease Treatment Market?
6. What is the market share of the leading vendors in the Global Fabry Disease Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Fabry Disease Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amicus Therapeutics Inc.
  • Avrobio Inc.
  • Greenovation Biotech GmbH
  • ISU Abxis Co Ltd.
  • Moderna Therapeutics Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Type Outlook
3.4. Region Outlook
3.5. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for messenger RNA as a treatment modality for Fabry disease
5.1.1.2. Adoption of novel therapies
5.1.1.3. Growing incidences of genetic disorders and increasing awareness
5.1.2. Restraints
5.1.2.1. Lack of awareness about advancements with respect to treatments for Fabry disease
5.1.2.2. High cost associated with the enzyme replacement therapy
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for the treatment of Fabry disease
5.1.3.2. Increasing healthcare expenditure and improving infrastructure in emerging economies
5.1.3.3. Increasing number of clinical trials
5.1.4. Challenges
5.1.4.1. Limitations in adopting new technologies in certain countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Fabry Disease Treatment Market, by Treatment Type
6.1. Introduction
6.2. Chaperone Treatment
6.3. Enzyme Replacement Therapy
6.4. Organ-specific Treatment
6.5. Substrate Reduction Therapy

7. Americas Fabry Disease Treatment Market
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States

8. Asia-Pacific Fabry Disease Treatment Market
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. Singapore
8.10. South Korea
8.11. Thailand

9. Europe, Middle East & Africa Fabry Disease Treatment Market
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis, By Key Player
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles
11.1. Amicus Therapeutics Inc.
11.2. Avrobio Inc.
11.3. Greenovation Biotech GmbH
11.4. Idorsia Pharmaceuticals Ltd.
11.5. ISU Abxis Co Ltd.
11.6. JCR Pharmaceuticals Co Ltd.
11.7. Moderna Therapeutics Inc.
11.8. Protalix Biotherapeutics Inc.
11.9. Sanofi S.A.
11.10. Shire Plc.

12. Appendix
12.1. Discussion Guide
12.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 4. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 5. GLOBAL FABRY DISEASE TREATMENT MARKET: MARKET DYNAMICS
FIGURE 6. GLOBAL FABRY DISEASE TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 7. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (%)
FIGURE 8. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2026
FIGURE 10. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, 2018-2026 (USD MILLION)
FIGURE 11. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 12. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 19. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 20. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 21. CANADA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 22. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 24. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. CHINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. INDIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. ITALY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. QATAR FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL FABRY DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 48. GLOBAL FABRY DISEASE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 49. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FABRY DISEASE TREATMENT MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL FABRY DISEASE TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 10. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 11. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 12. CANADA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. CHINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. INDIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. ITALY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. QATAR FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. GLOBAL FABRY DISEASE TREATMENT MARKET: SCORES
TABLE 39. GLOBAL FABRY DISEASE TREATMENT MARKET: BUSINESS STRATEGY
TABLE 40. GLOBAL FABRY DISEASE TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 41. GLOBAL FABRY DISEASE TREATMENT MARKET: RANKING
TABLE 42. GLOBAL FABRY DISEASE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 43. GLOBAL FABRY DISEASE TREATMENT MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL FABRY DISEASE TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL FABRY DISEASE TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL FABRY DISEASE TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL FABRY DISEASE TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL FABRY DISEASE TREATMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Amicus Therapeutics Inc.
  • Avrobio Inc.
  • Greenovation Biotech GmbH
  • Idorsia Pharmaceuticals Ltd.
  • ISU Abxis Co Ltd.
  • JCR Pharmaceuticals Co Ltd.
  • Moderna Therapeutics Inc.
  • Protalix Biotherapeutics Inc.
  • Sanofi S.A.
  • Shire Plc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll